1 week ago

RWA perps will outpace tokenization

Tokenization was crypto's first big export to TradFi. Perps are next, says Martin Lee, markets insight lead at DWF labs.

1 week ago

Breaking: Circle Receives New York Charter to Strengthen USDC Oversight

TLDR Circle received a limited-purpose trust charter from the New York Department of Financial Services. Circle Internet Trust Com...

1 week ago

Circle Secures New York Trust Charter, Strengthening USDC’s Regulatory Foundatio...

TLDR: NYDFS granted Circle New York Trust a limited purpose trust charter on July 31, 2026. Circle first received a BitLicense fro...

1 week ago

Eaton (ETN) Stock Rockets 7.89% on Exceptional Q2 Performance and Raised 2026 Fo...

Eaton (ETN) stock surged 7.89% after posting record Q2 sales, strong Electrical and Aerospace segment performance, and raising its...

1 week ago

Crypto News: USDC Issuer Circle Gets New York Trust Charter Approval

The post Crypto News: USDC Issuer Circle Gets New York Trust Charter Approval appeared first on Coinpedia Fintech NewsCircle Inte...

1 week ago

Intel (INTC) Stock Reclaims Momentum Near Key Resistance

TLDR Intel stock is recovering after falling more than 18% following earnings. Shares stabilized near $81.79 after dropping about...

1 week ago

Dubai-based crypto exchange tied to $4 billion Iran sanctioned-evasion network

Shelbit allegedly sent hundreds of millions of dollars to major crypto exchanges, including Binance, as it linked gambling sites a...

1 week ago

XRP News Today: Expert Calls CLARITY Act ‘Theater,’ Points to Real XRP Catalyst

The post XRP News Today: Expert Calls CLARITY Act ‘Theater,’ Points to Real XRP Catalyst appeared first on Coinpedia Fintech News...

1 week ago

Can Palantir (PLTR) Stock Recover After Q2 Earnings?

TLDR Palantir stock closed at $122.05, near its 52-week low. PLTR has fallen about 40% from its December record high. Palantir wil...

1 week ago

Moderna (MRNA) Stock Tumbles 6% Premarket Despite Improved Q2 Revenue Amid $782M...

Moderna (MRNA) stock declined 6% in premarket as Q2 revenue hit $145M, net loss narrowed to $782M, and norovirus vaccine trial mis...